SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-001634
Filing Date
2022-01-05
Accepted
2022-01-05 16:08:07
Documents
2
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4076
2 POA DOCUMENT poa.txt EX-24 4298
  Complete submission text file 0001209191-22-001634.txt   9874
Mailing Address C/O SUCAMPO PHARMACEUTICALS 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address
Meyenburg Jason Patrick (Reporting) CIK: 0001709008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 22511188

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations